Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion

[40] [41] Differential diagnosis [edit] Recognizing IPF in clinical practice can be challenging as symptoms often appear similar to those of more common diseases, such as asthma, chronic obstructive pulmonary disease (COPD) and congestive heart failure
10.5138/ijpm.2010.0975.0185.02031 40 LeoneA.SpadaA.BattezzatiA.SchiraldiA.AristilJ.BertoliS
New diagnosis rates were highest among women ages 25 to 34 (1.9%) and 18 to 24 (1.7%)
"'Food noise' is a term people use to describe constant thoughts about food," Dr